BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rzeniewicz K, Sharma R. Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease. World J Clin Oncol 2024; 15(11): 1394-1403 [PMID: 39582617 DOI: 10.5306/wjco.v15.i11.1394]
URL: https://www.wjgnet.com/2218-4333/full/v15/i11/1394.htm
Number Citing Articles
1
Hongkun Yin, Xusheng Zhang, Qi Wang. Trends and visualization analysis of research on MASLD-Related hepatocellular carcinoma: a bibliometric analysisDiscover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02858-9
2
Yi-Fan Zou, Yi-Gang Zhang, Zi-Chu Zhao, Zheng Li, Hong-Da Liu, Qing-Ya Li, Ze-Tian Chen, Cheng-Jun Zhu, Hai-Tao Liu, Ji-Wei Wang, Feng-Yuan Li, Lin-Jun Wang, Dian-Cai Zhang, Li Yang, Hao Xu, Ze-Kuan Xu, Sen Wang. Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomyWorld Journal of Gastrointestinal Surgery 2025; 17(9): 106198 doi: 10.4240/wjgs.v17.i9.106198